In terms of key secondary outcomes, mean changes from baseline in body weight at week 26 were -1.2 kg, -2.2 kg, and -3.1 kg for semaglutide 3 mg, 7 mg, and 14 mg, respectively
Factors such as medical history, other medications, pregnancy plans, and tolerance for side effects all play a role in determining whether this treatment is appropriate
Weight and BMI measurement
If you plan to stop, you need: Established protein and strength training habits (not Ill start training later) Regular daily activity baseline (10k+ steps, Zone 2 cardio) Structured eating patterns that dont rely on medication-induced appetite suppression Monitoring tools (scale, measurements, photos, strength metrics) Professional support (coach, dietitian, or medical provider) Taper under medical supervision